Delivery Order SPE2DR25D2106-SPE2DR26F1GFA
- Not listed
- The Defense Logistics Agency awarded a $3,214.56 delivery order to AmerisourceBergen Drug Corp on January 6, 2026, for the supply of Zepbound 7.5 mg/0.5 ml pen injections. This is a firm fixed-price, non-set-aside contract with a completion date of January 7, 2026, and performance will occur at the company's Conshohocken, Pennsylvania facility. AmerisourceBergen Drug Corp, a subsidiary of parent company Cencora, Inc., operates as a major pharmaceutical distributor serving federal healthcare...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $36,484.03 to AmerisourceBergen Drug Corp for the supply of Zepbound 7.5 mg/0.5 mL pen injections, with an ultimate completion date of January 7, 2026. This firm fixed-price delivery order was competitively awarded without set-aside restrictions and will be performed at the contractor's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a subsidiary of Cencora, Inc., is a major pharmaceutical distributor...
- The U.S. Department of Defense Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp for $8,777.80 to supply Zepbound 7.5 mg/0.5 ml pen injections, with an ultimate completion date of April 25, 2025. This firm fixed-price delivery order, awarded on April 24, 2025, represents a non-competitive set-aside purchase and will be fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The contract is a child award under AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 15, 2025, for the supply of Zepbound 7.5 mg/0.5 ml pen injections with a ceiling value of $3,481.58. This is a firm fixed-price, competitive delivery order with no set-aside designation, issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The order will be fulfilled from...
- The Defense Logistics Agency awarded a $12,764.07 firm fixed-price delivery order to AmerisourceBergen Drug Corp (Ultimate UEI: NWEGNLYTBDW4, operating under parent company Cencora, Inc.) on January 6, 2026, for the supply of Zepbound 5 mg/0.5 mL pen injections. The contract, which is a non-set-aside competitive award, carries an ultimate completion date of January 7, 2026, with performance occurring at the contractor's corporate office location in Conshohocken, Pennsylvania. This delivery order...
- The Defense Logistics Agency awarded a delivery order valued at $13,757.09 to AmerisourceBergen Drug Corp for the supply of Zepbound 7.5 mg/0.5 mL pen injections on December 1, 2025, with completion expected by December 2, 2025. This firm fixed-price delivery order was competitively awarded without set-aside designation and will be performed at AmerisourceBergen's Conshohocken, Pennsylvania facility. The contract falls under AmerisourceBergen's broader Indefinite Delivery Contract (IDC) with DLA...
- The Defense Logistics Agency awarded a delivery order valued at $48.4K to AmerisourceBergen Drug Corp for the supply of Zepbound 12.5 mg/0.5 mL pen injections on January 12, 2026, with completion scheduled for January 13, 2026. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at the awardee's corporate office location in Conshohocken, Pennsylvania. The contract represents a task order execution under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a $26,993.06 delivery order to AmerisourceBergen Drug Corp on July 18, 2025, for the supply of Zepbound 7.5 mg/0.5 mL pen injections, with an ultimate completion date of July 21, 2025. This competitively awarded, firm fixed-price contract carries no set-aside designation and is being performed at the vendor's corporate office location in Conshohocken, Pennsylvania. The delivery order is a child contract issued under AmerisourceBergen's larger Indefinite...
- The Defense Logistics Agency awarded a delivery order valued at $21,128.38 to AmerisourceBergen Drug Corp for the supply of Zepbound 7.5 mg/0.5 mL pen injections on June 18, 2025, with an ultimate completion date of June 20, 2025. This firm fixed price, non-set-aside contract represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The order will be fulfilled from...
- The Defense Logistics Agency awarded a $22,563.80 delivery order to AmerisourceBergen Drug Corp on January 8, 2026, for the supply of Zepbound 7.5 mg/0.5 ml pen injections. This firm fixed-price, non-set-aside contract has an ultimate completion date of January 9, 2026, with performance taking place at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's parent company Cencora, Inc.'s larger Indefinite Delivery Contract with...
- SPE2DR25D2106Indefinite Delivery Contract
- SPE2DR25D2106-SPE2DR26F1GFADelivery Order
The Defense Logistics Agency awarded a delivery order valued at $14,024.40 to AmerisourceBergen Drug Corp (UEI: KABZK8W6PQT3) on January 12, 2026, for the supply of Zepbound 7.5 mg/0.5 mL pen injections. This is a firm fixed-price, non-set-aside contract with performance in Conshohocken, Pennsylvania and an ultimate completion date of January 13, 2026. The delivery order is issued under AmerisourceBergen's parent company Cencora, Inc.'s larger Indefinite Delivery Contract with DLA Troop Support Medical (valued at up to $999,999,999.00 through December 2031), which serves as a comprehensive pharmaceutical supply vehicle for military healthcare programs globally. AmerisourceBergen, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, has demonstrated substantial capacity to fulfill federal medical procurement requirements through its extensive portfolio of competitively awarded contracts with the Defense Logistics Agency. The company supplies a wide range of pharmaceutical products across multiple therapeutic domains to support military treatment facilities and veterans' healthcare programs. This particular order for Zepbound, a diabetes medication, reflects the contractor's ongoing role as a critical vendor within the federal medical supply chain for defense and military healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $14.0k | 1/11/26 |